Use of cyanine dyes for the diagnosis of disease associated with angiogenesis

2007
OA: closed
AI-generated summary by qwen3.7-flash, 2026-09-11

This invention describes using cyanine dye conjugates with EB-D fibronectin binding components to diagnose micrometastasis, small proliferative lesions, and endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesions, in particular primary tumors, precancerosis, dysplasia, metaplasia, endometriosis, ocular diseases associated with angiogenesis, psoriasis, psoriatic arthritis and/or rheumatoid arthritis.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-15T06:15:18.721777+00:00